Copertina

Vesicular glutamate transporter VGLUT2 expression emerges in substantia nigra dopamine neurons in mouse models of parkinsonism in the absence of neurodegeneration

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Sivakumar Srinivasan, Christian Pifl, Thomas Steinkellner
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	British Journal of Pharmacology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Correction to “RTP801 is a critical factor in the neurodegeneration process of A53T a‐synuclein in a mouse model of Parkinson's disease under chronic restraint stress”
Pubblicazione: (2024)

Transient receptor potential ankyrin 1 channel modulates the abuse‐related mechanisms of methamphetamine through interaction with dopamine transporter
di: Kwang‐Hyun Hur, et al.
Pubblicazione: (2024)

Complement tunes glutamate release and supports synaptic impairments in an animal model of multiple sclerosis
di: Guendalina Olivero, et al.
Pubblicazione: (2024)

Advances in binding kinetics and mechanistic PK/PD modelling
di: Bharath Srinivasan
Pubblicazione: (2024)

Isoflurane and urethane impact neuronal and astroglial metabolic activity differentially in mouse brain: An ex vivo 1 H‐[ 13 C]‐NMR study
di: Sreemantula Arun Kumar, et al.
Pubblicazione: (2025)

TRPV4 stimulates colonic afferents through mucosal release of ATP and glutamate
di: Michelle Y. Meng, et al.
Pubblicazione: (2024)

Increased ATP production and P‐glycoprotein activity underlie the marked changes in blood–brain barrier transport of drugs in a mouse model of amyotrophic lateral sclerosis
di: Yijun Pan, et al.
Pubblicazione: (2025)

Matsupexole: A novel nonergot dopamine receptor agonist with sustained efficacy in a rat model of Parkinson's disease and limited off‐target activity
di: Takayuki Suzuki, et al.
Pubblicazione: (2026)

Clemastine attenuates subarachnoid haemorrhage pathology in a mouse model via Nrf2/SQSTM1‐mediated autophagy
di: Yan Zou, et al.
Pubblicazione: (2025)

A novel reuptake inhibitor, IP2015, induces erection by increasing central dopamine and peripheral nitric oxide release
di: Simon Comerma‐Steffensen, et al.
Pubblicazione: (2024)

Time‐evolved metrics for safety pharmacological assessments of small molecules and biologics
di: Bharath Srinivasan
Pubblicazione: (2025)

Intravenous recombinant cerebellin 1 treatment restores signalling by spinal glutamate delta 1 receptors and mitigates chronic pain
di: Siddhesh S. Sabnis, et al.
Pubblicazione: (2024)

FM‐dye inhibition of Piezo2 relieves mechanically evoked pain in mouse models of acute inflammatory and osteoarthritic knee pain
di: Natalie S. Adamczyk, et al.
Pubblicazione: (2026)

Sex‐specific impact of repeated adolescent vapour exposure to JWH‐018 on dopamine response, behaviour and pharmacokinetics across adolescence and adulthood
di: Nicholas Pintori, et al.
Pubblicazione: (2025)

Advancing Alzheimer's disease pharmacotherapy: efficacy of glucocorticoid modulation with dazucorilant (CORT113176) in preclinical mouse models
di: Geoffrey Canet, et al.
Pubblicazione: (2025)

SCA44‐ and SCAR13‐associated GRM1 mutations affect metabotropic glutamate receptor 1 function through distinct mechanisms
di: Yuyang Wang, et al.
Pubblicazione: (2024)

Blockade of cannabinoid CB1 receptors potentiates the anti‐fibrotic effects mediated by SGLT2 inhibition in a mouse model of diabetic nephropathy
di: Océane Pointeau, et al.
Pubblicazione: (2025)

A pH‐sensitive opioid does not exhibit analgesic tolerance in a mouse model of colonic inflammation
di: Claudius E. Degro, et al.
Pubblicazione: (2024)

Role for the liver X receptor agonist 22‐ketositosterol in preventing disease progression in an Alzheimer's disease mouse model
di: Nikita Martens, et al.
Pubblicazione: (2025)

Exploring the pathophysiology underlying clozapine‐induced enhancement of glutamatergic transmission through L‐glutamate and D‐serine release associated with pannexin1 hemichannels
di: Motohiro Okada, et al.
Pubblicazione: (2025)

Plumbagin, a novel TRPV2 inhibitor, ameliorates microglia activation and brain injury in a middle cerebral artery occlusion/reperfusion mouse model
di: Meihuizi Ding, et al.
Pubblicazione: (2024)

A p75 neurotrophin receptor‐sparing nerve growth factor protects retinal ganglion cells from neurodegeneration by targeting microglia
di: Laura Latini, et al.
Pubblicazione: (2024)

ESG‐1‐60 and ESG‐1‐61: Novel dopamine D3 receptor‐preferring partial agonists/antagonists that inhibit cocaine taking and seeking in rodents
di: Omar Soler‐Cedeño, et al.
Pubblicazione: (2025)

Biphasic effect of nicotine on glutamatergic activity in male mouse brain
di: Prajakta Pramod Biyani, et al.
Pubblicazione: (2025)

Pharmacokinetics and cardioprotective efficacy of intravenous miR‐125b* microRNA mimic in a mouse model of acute myocardial infarction
di: Tamara Szabados, et al.
Pubblicazione: (2024)

Decreased extrasynaptic δ‐GABAA receptors in PNN‐associated parvalbumin interneurons correlates with anxiety in APP and tau mouse models of Alzheimer's disease
di: Weicong Zhang, et al.
Pubblicazione: (2024)

GNS561 (ezurpimtrostat), a small basic lipophilic molecule, prevents lupus phenotype in a pristane‐induced lupus mouse model
di: Eya Toumi, et al.
Pubblicazione: (2025)

P2X7 receptor antagonism suppresses epileptiform‐like activity in an inflammation‐primed human iPSC‐derived neuron model of drug‐resistant epilepsy
di: Jaideep Kesavan, et al.
Pubblicazione: (2025)

The neuronal ALAS2/5‐ala axis mitigates chemotherapy‐induced neurotoxicity via the BACH1/NRF2 pathway
di: Wen‐yuan Zhang, et al.
Pubblicazione: (2026)

P2X7 receptor‐dependent increase in endocannabinoid 2‐arachidonoyl glycerol production by neuronal cells in culture: Dynamics and mechanism
di: Simar Singh, et al.
Pubblicazione: (2024)

Identification of active ingredients from Lamiophlomis rotata that increase wound repair in mouse skin
di: Huan Li, et al.
Pubblicazione: (2025)

Carvedilol inhibits neuronal hyperexcitability caused by epilepsy‐associated KCNT1 mutations
di: Chang Di, et al.
Pubblicazione: (2024)

Structural bases for stoichiometry‐selective calcium potentiation of a neuronal nicotinic receptor
di: Simone Mazzaferro, et al.
Pubblicazione: (2024)

Insight into the regulatory mechanism of β‐arrestin2 and its emerging role in diseases
di: Meng Qi, et al.
Pubblicazione: (2024)

NPY Y 1 and Y 2 receptors in the regulation of mouse recognition and procedural memory: Interplay with cellular signalling, noradrenergic transmission and monoamine concentrations
di: Agnieszka Michalak, et al.
Pubblicazione: (2025)

The ion channel TRPM8 is a direct target of the immunosuppressant rapamycin in primary sensory neurons
di: José Miguel Arcas, et al.
Pubblicazione: (2024)

The fast‐dissociating D 2 antagonist antipsychotic JNJ‐37822681 is a neuronal Kv7 channel opener: Potential repurposing for epilepsy treatment
di: Lidia Carotenuto, et al.
Pubblicazione: (2025)

Ventral pallidum GABAergic and glutamatergic neurons modulate arousal during sevoflurane general anaesthesia in male mice
di: Bing‐Qian Fan, et al.
Pubblicazione: (2025)

Cancer pain: current practice and emerging targets
di: Yi Ye, et al.
Pubblicazione: (2026)

Histone deacetylase‐mediated silencing of PSTPIP2 expression contributes to aristolochic acid nephropathy‐induced PANoptosis
di: Chuanting Xu, et al.
Pubblicazione: (2024)